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OBJECTIVE: Urea is commonly used as a keratolytic substance in the treatment of onychomycoses to improve the penetration
of antifungal drugs in the lesion sites. The aim of the present study was to investigate the inhibitory action of urea on samples of
dermatophytes in vitro.
METHOD: Minimum inhibitory concentration of urea was determined for 31 samples of dermatophytes cultured in Sabouraud-
dextrose broth containing different concentrations (7.5% up to 40%) of urea. Absence of growth was the criterion adopted to
determine the minimum inhibitory concentration.
RESULTS: The majority of samples (87%) were sensitive to urea at 12.5%, or less. 2 isolates of Trichophyton tonsurans and 2 of
Trichophyton rubrum required 30%, and 40% urea, respectively, to be completely inhibited.
CONCLUSION: In vitro results demonstrate inhibitory activity of urea on dermatophytes, suggesting that it could be used as an
adjuvant in topical treatments.
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INTRODUCTION
Dermatophytes are fungi capable of invading kerati-
nized regions such as skin, hair, and nails of human be-
ings and animals, causing diseases known as dermatophy-
toses.1 Among the species of anthropophilic dermatophytes,
Trichophyton rubrum is the most adapted to human beings
and is one of the most important agents of tinea unguium,
tinea pedis, tinea manuum, tinea corporis, and tinea capi-
tis.2–10 Treatment with topical antimycotics are generally not
indicated for hyperkeratotic type tinea pedis and ony-
chomycoses. In these cases, griseofulvine and, more re-
cently, itraconazole and terbinafine have been frequently
administered. However, such drugs can cause intestinal and
hepatic disturbances or interactions with other consumed
drugs, precluding oral treatment.11
Several agents for topical use are commercially avail-
able for the treatment of superficial mycoses. The medi-
cation is prescribed according to the etiology of the fun-
gus, site, and extent of the lesions. Clinical aspects of the
host are important for establishing the choice of a topical
or systemic treatment.12
Treatment is usually prolonged for hyperkeratotic le-
sions of the feet and nails. In order to shorten it, drugs as-
sociated with keratolytic agents have been tested. Studies
have shown that bifonazole plus urea can be useful in this
situation.12-14,16 The application of urea along with
butenafine can also result in earlier improvement of der-
matological symptoms of hyperkeratotic-type tinea pedis15
as well as when associated with lanoconazole.11
In summary, these studies have shown that the kerato-
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lytic/exfoliative action of urea can reduce the period of
treatment of hyperkeratotic lesions. However, there are no
reports on the inhibitory activity of urea on dermatophytes,
except for the work of Faergemann & Swanbeck17 who in-
vestigated the in vitro action of urea against a sample of
T. rubrum, demonstrating that the minimal inhibitory con-
centration (MIC) of a solution containing urea, lactic acid,
and propylene glycol was lower in comparison to the same
solution without urea.
The aim of this study was to evaluate in vitro the in-
hibitory activity of urea on dermatophytes samples.
MATERIALS AND METHODS
Microorganisms
Thirty-one samples of dermatophytes isolated from pa-
tients presenting skin (n = 18) and nail lesions (n = 13)
were analyzed (Table 1).
Sample Identification
Initially, a direct examination of the samples treated with
KOH 20% was performed by optical microscopy. Then, the
samples were cultured in tubes containing mycobiotic agar
and maintained at 25ºC. The macroscopic aspect of the colo-
nies was observed during a 2-week period.
To identify the isolate at genus and species level,
microcultures of the dermatophytes were carried out in po-
tato agar maintained at 25ºC, followed by microscopic ex-
amination of the slides stained with lactophenol cotton blue.
Susceptibility to urea
In order to determine the in vitro sensitivity to urea,
all the dermatophytes samples were cultured in 18 x 180
mm tubes with 10 mL of Sabouraud-dextrose broth hav-
ing the following concentrations of urea: 7.5%, 10%,
12.5%, 20%, 30%, and 40%. All the cultures were incu-
bated at 30ºC. Tubes containing only Sabouraud-dextrose
broth as culture medium were used as positive growth con-
trols.
Minimal inhibitory concentration (MIC)
determination
Absence of growth was the criterion adopted to define
the MIC of urea, which was determined between the 7th
Table 1 – Dermatophyte identification of 31 clinical samples studied
Samples Reference number Location Origin
T. rubrum 11 Inguinal region Laboratory of Mycology – IMT
T. rubrum 16 Foot Laboratory of Mycology – IMT
T. rubrum 22 Foot Dermatology Service–HCFMUSP
T. rubrum 25 Foot Dermatology Service – HCFMUSP
T. rubrum 29 Foot Proença Laboratory
T. rubrum 56 Foot Dermatology Service – HCFMUSP
T. rubrum 68 Foot Proença Laboratory
T. rubrum 70 Foot Proença Laboratory
T. rubrum 109 Nail Laboratory of Mycology – IMT
T. rubrum 114 Nail Laboratory of Mycology – IMT
T. rubrum 115 Nail Laboratory of Mycology - IMT
T. rubrum 117 Foot Laboratory of Mycology – IMT
T. rubrum 118 Foot Laboratory of Mycology – IMT
T. rubrum 119 Foot Laboratory of Mycology – IMT
T. rubrum 121 Glutea region Laboratory of Mycology – IMT
T. rubrum 126 Nail Laboratory of Mycology – IMT
T. rubrum 154 Nail Proença Laboratory
T. rubrum 155 Nail Laboratory of Mycology – IMT
T. rubrum 156 Nail Laboratory of Mycology – IMT
T. tonsurans 04 Scalp Laboratory of Mycology – IMT
T. tonsurans 06 Nail Dermatology Service –HCFMUSP
T. tonsurans 09 Foot Laboratory of Mycology – IMT
T. tonsurans 24 Foot Dermatology Service –HCFMUSP
T. tonsurans 34 Nail Laboratory of Mycology – IMT
T. tonsurans 125 Nail Proença Laboratory
T. mentagrophytes 10 Foot Laboratory of Mycology – IMT
T. mentagrophytes 33 Nail Proença Laboratory
T. mentagrophytes 83 Nail Laboratory of Mycology – IMT
T. mentagrophytes 153 Foot Laboratory of Mycology – IMT
M. canis 142 Nail Proença Laboratory
M. gypseum 110 Foot Brigadeiro Hospital
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and 10th day, when the control tube had well developed
typical colonies.
The growth of the samples during the incubation time was
recorded and graded as follows: C = control tube (plentiful
growth); (+) = weak growth; (++) = moderate growth; (+++)
= plentiful growth; (-) = absence of growth (Figure 1).
RESULTS
The causative agents in 31 samples of dermatophytes
from patients presenting skin and nails lesions were iden-
tified as Trichophyton rubrum (19), Trichophyton tonsurans
(6), Trichophyton mentagrophytes (4), Microsporum
gypseum (1), and Microsporum canis (1) (Table 1).
Of note is the high frequency of T. rubrum in feet and
nails in the samples that showed growth inhibition
atconcentrations lower or equal to 10%.
Two T. tonsurans isolates were sensitive at 30% urea,
and 2 T. rubrum isolates were sensitive at 40% (Table 2).
The sample distribution according to the lesion site is
presented in Table 3.
Table 2 - Growth index of 31 isolates of dermatophytes sown in Sabouraud-dextrose broth at 30°C in the presence of
different concentrations of urea
Urea  Concentrations (%)
Samples C* 7.5% 10% 12.5% 20% 30% 40%
T. rubrum (11) +++ ** +++ +++ - - - -
T. rubrum (16) +++ - - - - - -
T. rubrum (22) +++ + + - - - -
T. rubrum (25) +++ + + - - - -
T. rubrum (29) +++ - - - - - -
T. rubrum (56) ++ - - - - - -
T. rubrum (68) +++ +++ +++ - - - -
T. rubrum (70) +++ ++ - - - - -
T. rubrum (109) +++ - - - - - -
T. rubrum (114) +++ +++ +++ ++ ++ + -
T. rubrum (115) +++ +++ +++ ++ ++ ++ -
T. rubrum (117) +++ +++ +++ - - - -
T. rubrum (118) +++ +++ +++ - - - -
T. rubrum (119) +++ +++ +++ - - - -
T. rubrum (121) +++ +++ +++ - - - -
T. rubrum (126) +++ ++ ++ - - - -
T. rubrum (154) +++ - - - - - -
T. rubrum (155) +++ + - - - - -
T. rubrum (156) +++ + + - - - -
T. tonsurans (04) +++ + + - - - -
T. tonsurans (06) +++ ++ - - - - -
T. tonsurans (09) +++ +++ ++ ++ ++ - -
T. tonsurans (24) +++ ++ - - - - -
T. tonsurans (34) +++ +++ +++ - - - -
T. tonsurans (125) +++ +++ +++ ++ ++ - -
T. mentagrophyte(10) +++ +++ +++ - - - -
T. mentagrophyte(33) +++ ++ + - - - -
T.mentagrophytes(83) +++ ++ - - - - -
T. mentagrophytes(153) +++ + - - - - -
M. gypseum (110) +++ - - - - - -
M. gypseum (161) +++ ++ - - - - -
M. canis (142) ++ - - - - - -
*C = control tube (plentiful growth); ** Growth index: + weak growth; ++ moderate growth; +++ plentiful growth; - absence of growth
(+++) = plentiful growth (++) = moderate growth
(+) = weak growth (-) = absence of growth
Figure 1 - Illustration of the classification scheme of growth patterns of
dermatophytes during the incubation of the samples in the presence or
absence of urea.
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DISCUSSION
Most dermatologists use topical formulations of anti-
fungal drugs. The choice of treatment depends on the
etiology, location, clinical form, and extent of the fungal
lesions. In many cases, the patient’s underlying conditions
determine the treatment choice: creams, solutions, powders,
gels, or capsules.12
The therapeutic schemes for hyperkeratotic type tinea
pedis and onychomycosis, mainly for the toenails, are se-
riously problematic, because the results with griseofulvine
are not sufficiently satisfactory and side effects are frequent.
More recently, itraconazole and terbinafine have been used.
These antifungal agents produce fewer side effects, but their
high cost can make the treatment impractical.
Additionally, topical antifungal drugs are also unsatis-
factory due to the poor penetration into the nails. However,
earlier studies have shown that the use of propyleneglycol
associated with urea and lactic acid produces effective re-
sults for the treatment of the nail tissue. Among 23 patients
presenting onychomycosis caused by Candida albicans and
Trichophyton rubrum, 21 had good in vivo responses with
only topical treatment using this combination.17
The association of topical antifungal drugs with urea
has been shown to improve treatment outcomes. Associa-
tion of bifonazole with 10% urea to treat patients with tinea
pedis produced clinical improvement in 92% of the cases
after 12 weeks. Additionally, the treatment of the hyperk-
eratotic-type tinea pedis with topic butenafine hydrochlo-
ride plus 20% urea provided an earlier dermatological im-
provement compared to the use of oral antifungal drugs.15
Regarding etiologies among the dermatophytoses, T.
rubrum has been shown to have a high incidence as a causa-
tive agent.16,18,20 In our study, the most frequently isolated
dermatophyte from different body regions was T. rubrum.
An earlier study evidenced the antimycotic activity of
urea at 5% against a T rubrum isolate in vitro.17 Our data
show that the majority of samples, including T. rubrum,
were sensitive to 12.5% urea. Of note is that only 4 iso-
lates, 2 of T. tonsurans and 2 of T. rubrum, respectively,
required 30% or 40% urea for their complete inhibition.
These data are related to clinical observations, because le-
sions caused by T. rubrum are sometimes difficult to treat,
and recurrence frequently occurs.21
These in vitro results demonstrate the inhibitory activ-
ity of urea on dermatophytes, suggesting that this kerato-
lytic agent may also have a fungicide action and that it
could be used as an adjuvant in topical treatment. Further
studies correlating time of treatment and cure percentage
of patients using topical medications in the presence of urea
must be conducted for a better evaluation of its antimy-
cotic action.
Table 3 - Distribution of dermatophytes isolates by lesion site
Lesion Sites Dermatophytes Total
T. tonsurans T. rubrum T. mentagrophytes M. canis M. gypseum
Nail 03 07 02 - - 13
Scalp 01 - - - - 01
Glútea region - 01 - - - 01
Foot 02 10 02 - 01 15
Inguinal region - 01 - - - 01
Total 06 19 04 01 02 31
RESUMO
Martins JEC, Corim SM, Arriagada GLH, Melo NT de,
Heins EM. Sensibilidade in vitro de dermatófitos à uréia.
Clinics. 2006;61(1):9-14.
OBJETIVO: A uréia é comumente usada como substância
queratolítica no tratamento das onicomicoses no intuito de
melhorar a penetração das drogas antifúngicas. O objetivo
deste estudo foi investigar a ação inibitória in vitro da uréia
em amostras de dermatófitos
MÉTODOS: A concentração inibitória mínima da uréia foi
determinada para trinta e uma amostras de dermatófitos
semeadas em meio de cultura Sabouraud-dextrose contendo
diferentes concentrações (7,5% até 40%) de uréia. Ausência
de crescimento foi o critério adotado para a determinação
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da concentração inibitória mínima.
RESULTADOS: A maioria das amostras (87%) foi sensível
à uréia em concentrações de 12,5% ou menos. Apenas dois
isolados de Trichophyton tonsurans e dois de Trichophy-
ton rubrum foram inibidos completamente na presença de
30% e 40% de uréia, respectivamente.
CONCLUSÃO: Os resultados in vitro demonstraram
atividade inibitória da uréia sobre os dermatófitos, sugerindo
que possa ser usada como um adjuvante em tratamentos
tópicos.
UNITERMOS: Onicomicoses. Dermatomicoses. Dermató-
fitos. Uréia. Ação Inibitória.
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